Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Orphazyme A/S ADR
(NQ:
ORPH
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 30, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Orphazyme A/S ADR
< Previous
1
2
3
4
5
6
Next >
85 Biggest Movers From Yesterday
August 11, 2021
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
Dear ORPH Stock Fans, Mark Your Calendars for August 31
August 10, 2021
Today, investors appear to be pricing some positive news and a potential short squeeze into ORPH stock, as Orphazyme shoots higher.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
August 05, 2021
During Thursday's morning session, 77 companies made new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low...
Via
Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 04, 2021
Wednesday's morning session saw 58 companies set new 52-week lows. Noteworthy Mentions: The company with the largest market cap to set a new 52-week low was...
Via
Benzinga
Orphazyme Stock Is a Dead-End for Investors After FDA Rejection
July 16, 2021
ORPH stock has a virtually impossible task ahead of it in picking itself after FDA's rejection of the Danish biopharma's Arimoclomol drug.
Via
InvestorPlace
Exposures
Product Safety
Orphazyme’s Massive Price Appreciation Won’t Be Captured Again
July 08, 2021
ORPH stock multiplied overnight to lofty highs, but it clearly won't happen again due to its very small market capitalization.
Via
InvestorPlace
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Orphazyme A/S May Look Like a Long Shot, but Things Aren’t That Dire
July 07, 2021
The odds of positive subsequent news, and a short squeeze, could outweigh the risk dilution and more disappointment sends ORPH stock lower.
Via
InvestorPlace
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
July 01, 2021
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive...
Via
Benzinga
Despite FDA Disappointment, All Hope Isn’t Lost for Orphazyme
July 01, 2021
Resilient ORPH stock bulls managed to hold their ground even amid a regulatory setback. Could a major rally be just around the corner?
Via
InvestorPlace
Exposures
Product Safety
ORPH Stock: The Big News That Has Red-Hot Orphazyme Gaining Today
June 29, 2021
Two key announcements from Orphazyme are sending shares of ORPH stock higher today, as investors continue to reprice this biopharma stock.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 29, 2021
Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) stock moved upwards by 93.55% to $24.33 during Tuesday's regular session. As of 12:30 EST, this security is trading at...
Via
Benzinga
Orphazyme To Cut Two-Third Workforce Under Restructuring; Reaffirms FY21 Outlook
June 28, 2021
Orphazyme A/S (NASDAQ: ORPH) plans an approximate two-thirds reduction in its global workforce due to a restructuring, aiming to advance its corporate strategy and...
Via
Benzinga
45 Biggest Movers From Yesterday
June 25, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads...
Via
Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
June 24, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 24, 2021
Gainers Aravive (NASDAQ:ARAV) stock moved upwards by 21.61% to $6.47 during Thursday's pre-market session. The company's market cap stands at $131.9 million. Arcus...
Via
Benzinga
25 Stocks Moving in Thursday's Pre-Market Session
June 24, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) rose 43.3% to $2.45 in pre-market trading after the company announced it has added the ability to manage Instacart Ads to its...
Via
Benzinga
45 Biggest Movers From Yesterday
June 24, 2021
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613. First...
Via
Benzinga
Why Orphazyme Stock Skyrocketed 24.6% Today
June 23, 2021
Goldman Sachs upped its stake in the drugmaker -- but only briefly.
Via
The Motley Fool
ORPH Stock: Why Orphazyme Is Gaining Today Despite FDA Disappointment
June 23, 2021
Today's massive upward move in ORPH stock appears to be the result of a disclosed stake in the company of more than 5% from Goldman Sachs.
Via
InvestorPlace
Exposures
Product Safety
Why Entera Bio, Orphazyme, Bellerophon Are Moving Today
June 23, 2021
Entera Bio Ltd. (NASDAQ: ENTX), Orphazyme A/S (NASDAQ: ORPH) and Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) are among the biggest biopharma movers Wednesday. Entera Bio Climbs...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 23, 2021
Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 32.66% to $7.92 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of...
Via
Benzinga
Former Wall Street Floor Trader: Tesla Is Going To $700
June 23, 2021
Longtime trader David Green thinks Tesla Inc (NASDAQ:TSLA)...
Via
Benzinga
31 Stocks Moving In Wednesday's Mid-Day Session
June 23, 2021
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613. Orphazyme A/S (NASDAQ: ORPH)...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 22, 2021
Gainers vTv Therapeutics (NASDAQ:VTVT) shares rose 30.08% to $3.07 during Tuesday's pre-market session. The company's market cap stands at $251.7 million. Adial...
Via
Benzinga
48 Biggest Movers From Yesterday
June 22, 2021
Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,...
Via
Benzinga
Assess Biotech Landscape Hazards Before Trading Orphazyme Stock
June 22, 2021
While I won’t bother making a strong bull nor bear case for ORPH stock, you do need to perform your due diligence before placing a bet.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.